跳至主要内容
临床试验/NCT01050933
NCT01050933终止1 期

Safety and Tolerability of Inhaled Carbon Monoxide in Healthy Volunteers

Queen's University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
10
试验地点
1
主要终点
Adverse Event Rate

研究概览

简要总结

Post operative ileus (POI), a temporary paralysis of the intestines, is a serious health care problem. It normally occurs in all patients after surgery to the abdomen but in some cases can result in serious complications. The objective of this study is to determine if inhaling very low doses of carbon monoxide (CO) before and after colon surgery will shorten the duration of normal POI and/or prevent the development of POI complications in patients undergoing colon surgery.

This preliminary study will be conducted in ten healthy volunteers to monitor for blood levels and adverse effects that occur at different durations of exposure of inhaled CO to establish a safe dose for patients in the main trial. For the main trial, patients requiring surgery to their colon will be assigned randomly to receive one hour treatments of either CO or oxygen by face mask before and after their operation.

We hypothesize that healthy volunteers will be able to tolerate 1 hour doses of 250 ppm of CO with minimal side effects. It is also anticipated that for each dose of CO administered, the blood levels of CO will remain well under poisonous levels. Finally, we anticipate blood levels of CO will return to baseline level within 24 hours following the last dose of CO.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women, age > 18 years.
  • Women must be using acceptable contraceptives, post-menopausal or surgically sterile.
  • No prior smoking history.
  • BMI between 16 and 30 inclusive.
  • In good health as per medical history, physical exam, vital signs & ECG.

排除标准

  • Exposure to carbon monoxide during the 48 hours prior to the study day.
  • Occupational exposure to CO.
  • Significant disease that may put the volunteer at risk because of participation in the study or may influence the results of the study or the volunteer's ability to participate in the study.
  • Baseline blood level of COHb >2%.
  • Patients with underlying lung disease such as asthma or COPD.
  • Baseline oxygen saturation <92% on room air.
  • Planned pregnancy, already pregnant or breastfeeding.
  • Participation in another clinical trial within 2 months prior to study.

研究组 & 干预措施

Carbon Monoxide

Experimental

Healthy volunteers will receive 250 ppm of carbon monoxide by face mask. This dose will be administered for 1 hour with continuous COHb monitoring. At baseline and at each half hour time point, a blood sample will be drawn to be analyzed by the gas chromatograph. After 1 hour, the volunteer will be excused and asked to return in 4 hours and this procedure repeated. At any point, if the COHb level reaches 10%, administration of CO will be terminated.

干预措施: 250 ppm carbon monoxide (Drug)

结局指标

主要结局

Adverse Event Rate

时间窗: Before and after carbon monoxide exposure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Paul Belliveau

Principal Investigator

Queen's University

研究点 (1)

Loading locations...

相似试验